C7A.024
Malignant carcinoid tumor of the descending colon
Clinical Classification Guidelines
Medical Intelligence & Overview
A malignant carcinoid tumor of the descending colon is a rare form of cancer that originates from neuroendocrine cells in the lining of the colon. Although it is classified as a malignant tumor, it tends to grow slowly and may not cause noticeable symptoms in its early stages. This tumor can potentially spread to other parts of the body if not diagnosed and treated appropriately. Recognizing this condition early is crucial for effective management and improving outcomes.
Causes & Symptoms
Clinical Causes: Genetic mutations affecting neuroendocrine cells Environmental factors such as exposure to carcinogens Chronic inflammatory conditions of the colon Family history of neuroendocrine tumors or other gastrointestinal cancers Age-related changes, as these tumors are more common in older adults
Key Symptoms: Changes in bowel habits, such as diarrhea or constipation Abdominal pain or discomfort Unexplained weight loss Occasional bleeding or anemia Mucus in stool Feeling of fullness or bloating
Diagnostic & Treatment
Diagnosis Path: Diagnosis of a malignant carcinoid tumor in the descending colon involves several steps. Physicians typically start with a physical exam and review of medical history. Diagnostic procedures include:
Treatment Protocols: Treatment options for a malignant carcinoid tumor of the descending colon depend on the size, location, and extent of the disease. Common approaches include:
Clinical Advice & FAQs
Billing Guidance
Is C7A.024 a billable ICD-10 code?
Yes, C7A.024 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.
Documentation
How do I report C7A.024?
Clinical documentation must specify the nature of Malignant carcinoid tumor of the descending colon and any associated comorbidities for accurate reporting.
Cite this Clinical Reference